A carregar...
Systemic and Adjuvant Therapies for Intrahepatic Cholangiocarcinoma
Intrahepatic cholangiocarcinoma represents the second most common primary liver cancer and is increasing in incidence. Most patients are diagnosed at an advanced, nonsurgical stage and only about 1 in 5 cases are surgically resectable. Despite surgery, the 5-year survival is low at only 30%. Multifo...
Na minha lista:
| Publicado no: | Cancer Control |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5937242/ https://ncbi.nlm.nih.gov/pubmed/28975832 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1073274817729241 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|